Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden × Decitabine × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 45 Myelodysplastic Syndromes 23 Leukemia, Myelomonocytic, Chronic 11 Leukemia 9 Recurrence 6 Myelodysplastic-Myeloproliferative Diseases 3 Lymphoma, Large B-Cell, Diffuse 3 Leukemia, Biphenotypic, Acute 3 Primary Myelofibrosis 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Ovarian Neoplasms 2 Myeloproliferative Disorders 2 Lymphoma 2 Leukemia, Myelomonocytic, Acute 2 Leukemia, Monocytic, Acute 2 Head and Neck Neoplasms 2 Triple Negative Breast Neoplasms 1 Thrombocythemia, Essential 1 Systemic Mastocytosis With an Associated Hematologic Neoplasm 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Preleukemia 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pathologic Complete Response 1 Pancreatic Adenocarcinoma Metastatic 1 Older Patients 1 Neoplasms 1 Myeloid Malignancies 1 Melanoma 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡